Targeted Therapies

0.0(0)
studied byStudied by 0 people
0.0(0)
call with kaiCall with Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/232

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 9:04 AM on 10/2/25
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

233 Terms

1
New cards

Attack proliferative and metabolic pathways unique to malignant cells

What is one mechanism by which targeted therapy molecules work, concerning pathways?

2
New cards

Identify unique signatures of malignant cells and call on the immune system to destroy these cells

What is one mechanism by which targeted therapy molecules work, involving the immune system?

3
New cards

Targets rapidly dividing cells (mostly cancer cells)

How does chemotherapy primarily work?

4
New cards

Hair loss, intestinal damage, nausea

What are common side effects of chemotherapy?

5
New cards

Cancer cells develop resistance to chemotherapy, not specific

What are limitations of chemotherapy?

6
New cards

Targets Proteins required for cancer growth

How does targeted therapy primarily work?

7
New cards

Liver problems, diarrhea, skin rash

What are common side effects of targeted therapy?

8
New cards

Cancer cells develop resistance

What is a limitation of targeted therapy?

9
New cards

Uses our immune system against cancer

How does immunotherapy primarily work?

10
New cards

Autoimmune effects

What are side effects associated with immunotherapy?

11
New cards

Tailored and expensive

What are limitations of immunotherapy?

12
New cards

Sustaining proliferative growth

What cancer hallmark involves continuous cell multiplication?

13
New cards

Evading immune destruction

What cancer hallmark involves avoiding attack by the body's defense system?

14
New cards

Aerobic glycolysis

What metabolic process is listed under the hallmark of Deregulating metabolism?

15
New cards

anti-CTLA4 mAb

What is an example of a therapeutic strategy for Evading immune activating signaling suppressors?

16
New cards

BH3 mimetics

What is an example of a therapeutic strategy for Resisting cell death?

17
New cards

Telomerase Inhibitors

What is the therapeutic strategy targeting Enabling replicative immortality?

18
New cards

PARP inhibitors

What is a therapeutic strategy listed for Genome instability & mutation?

19
New cards

Selective anti-inflammatory drugs

What is a therapeutic strategy for Tumor promoting inflammation?

20
New cards

Inhibitors of angiogenesis

What therapeutic strategy targets Inducing angiogenesis?

21
New cards

Inhibitors of invasion & metastasis

What therapeutic strategy targets Enabling invasion & metastasis?

22
New cards

EGFR inhibitors, HER2 antibodies

What are examples of therapies targeting Sustaining proliferative signaling?

23
New cards

Inhibit cell-cycle regulators

What therapeutic strategy targets Evading growth suppressors?

24
New cards

CDK4/6 inhibitors

What is an example of a therapy that inhibits cell-cycle regulators to target Evading growth suppressors?

25
New cards

Promote apoptosis

What therapeutic strategy targets Resisting cell death?

26
New cards

BCL-2 inhibitors

What is an example of a therapy that promotes apoptosis to target Resisting cell death?

27
New cards

Block angiogenesis

What therapeutic strategy targets Inducing/accessing vasculature?

28
New cards

VEGF inhibitors

What is an example of a therapy used to block angiogenesis?

29
New cards

Disrupt tumor metabolism

What therapeutic strategy targets Deregulating metabolism?

30
New cards

Glycolysis inhibitors; metabolic modulators

What are examples of therapies used to disrupt tumor metabolism?

31
New cards

Target telomerase pathways (emerging)

What therapeutic strategy targets Enabling replicative immortality?

32
New cards

Under clinical investigation

What is the current status of therapies targeting Enabling replicative immortality (telomerase pathways)?

33
New cards

Unleash T-cell response

What therapeutic strategy targets Avoiding immune destruction?

34
New cards

Checkpoint inhibitors (PD-1, PD-L1, CTLA-4)

What are examples of therapies used to unleash the T-cell response to combat Avoiding immune destruction?

35
New cards

Sensitize tumors to immune or targeted therapies

What therapeutic strategy targets Unlocking phenotypic plasticity / Epigenetic reprogramming?

36
New cards

Emerging combination strategies

What type of strategies are used to target Unlocking phenotypic plasticity / Epigenetic reprogramming?

37
New cards

PARP inhibitors in BRCA-mutant

What is a specific example of a therapy related to Genomic instability & mutation?

38
New cards

Monoclonal antibodies, Drug-antibody conjugate, Small molecule inhibitors, Signaling inhibitors, Angiogenesis inhibitors, Hormonal Therapy, Immune checkpoint inhibitors, Immunotherapy

Name the major classes of targeted therapy listed.

39
New cards

Direct killing, Toxin, BiTE, Phagocytosis, ADCC, Blockage of inhibitory checkpoint molecules

List the mechanisms of action of Monoclonal Antibodies.

40
New cards

Toxin

Monoclonal antibodies can be conjugated to what substance for targeted delivery?

41
New cards

Phagocytosis

What mechanism of mAb action involves engulfment by immune cells?

42
New cards

Blockage of inhibitory checkpoint molecules

How do some mAbs act on the immune system regarding checkpoints?

43
New cards

Fc-receptor

What receptor on a Macrophage is involved in ADCC?

44
New cards

EGFR activation

What initiates the activation of downstream signaling pathways in an epithelial cell?

45
New cards

Proliferation, Survival, Vascular Permeability, Lymphangiogenesis, Migration

What are downstream cellular effects of EGFR activation listed?

46
New cards

HSC Survival, Monocyte Chemotaxis, Inhibition of DC Maturation

What are other listed downstream cellular processes related to EGFR activation?

47
New cards

PD-L1

What molecule binds to PD-1 and inhibits T cell killing of a tumor cell?

48
New cards

Blocking PD-L1 or PD-1

What action allows T cell killing of a tumor cell?

49
New cards

CD52

What is the antibody target for alemtuzumab?

50
New cards

B-cell chronic lymphocytic leukemia

What is the indication for alemtuzumab (targeting CD52)?

51
New cards

PD-L1

What is the target of atezolizumab and avelumab?

52
New cards

Metastatic non-small cell lung cancer, Urothelial carcinoma

What are the indications for atezolizumab?

53
New cards

Metastatic Merkel cell carcinoma

What is the indication for avelumab?

54
New cards

VEGF

What is the target of bevacizumab?

55
New cards

Metastatic colorectal cancer

What is the indication for bevacizumab?

56
New cards

CD19

What is the target of blinatumomab?

57
New cards

Precursor B-cell acute lymphoblastic leukemia

What is the indication for blinatumomab?

58
New cards

CD30

What is the target of brentuximab vedotin?

59
New cards

Hodgkin lymphoma, Anaplastic large-cell lymphoma

What are the indications for brentuximab vedotin?

60
New cards

EGFR

What is the target of cetuximab?

61
New cards

Metastatic colorectal carcinoma

What is the indication for cetuximab?

62
New cards

CD38

What is the target of daratumumab?

63
New cards

Multiple myeloma

What is the indication for daratumumab, elotuzumab, and Panobinostat?

64
New cards

IL4RA

What is the target of dupilumab?

65
New cards

Atopic dermatitis, asthma

What are the indications for dupilumab?

66
New cards

SLAMF7

What is the target of elotuzumab?

67
New cards

CD33

What is the target of gemtuzumab ozogamicin?

68
New cards

Acute myeloid leukemia

What is the indication for gemtuzumab ozogamicin?

69
New cards

CD20

What is the target of ibritumomab tiuxetan, obinutuzumab, ofatumumab, and rituximab?

70
New cards

Relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma

What is the indication for ibritumomab tiuxetan?

71
New cards

CD22

What is the target of inotuzumab ozogamicin?

72
New cards

Precursor B-cell acute lymphoblastic leukemia

What is the indication for inotuzumab ozogamicin?

73
New cards

CTLA-4

What is the target of ipilimumab?

74
New cards

Metastatic melanoma

What is the indication for ipilimumab, nivolumab, and pembrolizumab?

75
New cards

EGFR

What is the target of necitumumab?

76
New cards

Metastatic squamous non-small cell lung carcinoma

What is the indication for necitumumab and nivolumab?

77
New cards

PD-1

What is the target of nivolumab and pembrolizumab?

78
New cards

Chronic lymphocytic leukemia

What are the indications for obinutuzumab and ofatumumab?

79
New cards

Metastatic breast cancer

What is the indication for pertuzumab and trastuzumab?

80
New cards

HER2

What is the target of pertuzumab and trastuzumab?

81
New cards

VEGFR2

What is the target of ramucirumab?

82
New cards

Gastric cancer

What is the indication for ramucirumab?

83
New cards

B-cell non-Hodgkin's lymphoma

What is the indication for rituximab?

84
New cards

Infusion reactions / Allergic reactions, Cytokine release syndrome, Fever, chills, Weakness, headache, Nausea, vomiting, diarrhea

What are general adverse effects associated with monoclonal antibodies?

85
New cards

Cardiomyopathy

What specific adverse effect is associated with trastuzumab?

86
New cards

RTK (ABL, KIT, POGFR, HER, ALK, ROS, MET, FGFR, TRK, FLT3, CSFIR, VEGFR)

What family of targets do many small molecule inhibitors address?

87
New cards

ABL, KIT, PDGFR, SCF

What are the primary targets of Imatinib (Gleevec)?

88
New cards

Ph-positive CML, Ph-positive ALL, PDGFR rearrangements MDS/MPD, ASM, HES, CEL, DFSP, KIT-positive GIST

What are the indications for Imatinib, Dasatinib, and Nilotinib?

89
New cards

KIT, PDGFRA mutations, PDGFRB, TIE2, VEGFR2, BRAF

What are the targets of Ripretinib (Quinlock)?

90
New cards

GIST

What is the indication for Ripretinib (Quinlock)?

91
New cards

EGFR and HER family

What are the targets of Gefitinib (Iressa)?

92
New cards

NSCLC

What is the indication for Gefitinib (Iressa)?

93
New cards

Cyclin D

Which protein is involved in the G1/S checkpoint of the Cell Cycle shown in the diagram?

94
New cards

NSCLC with EGFR 19del or L858R, pancreatic cancer

What are the indications for Erlotinib (Tarceva)?

95
New cards

NSCLC with nonresistant EGFR mutations, squamous NSCLC

What are the indications for Afatinib (Gilotrif)?

96
New cards

NSCLC with EGFR 19del or L858R, NSCLC with T790M positive

What are the indications for Osimertinib (Tagrisso)?

97
New cards

HER2-positive breast cancer

What is the indication for Lapatinib (Tykerb), Neratinib (Nerlynx), and Tucatinib (Tukysa)?

98
New cards

EGFR and HER family

What are the targets shared by Erlotinib, Afatinib, Osimertinib, Lapatinib, Neratinib, and Tucatinib?

99
New cards

ALK, HGFR, c-Met, ROS1, RON

What are the targets of Crizotinib (Xalkori), Ceritinib (Zykadia), Alectinib (Alecensa), Brigatinib (Alunbrig), and Lorlatinib (Lorviqua)?

100
New cards

ALK- or ROS1-positive NSCLC, ALK-positive anaplastic large cell lymphoma

What are the indications for Crizotinib, Ceritinib, Alectinib, Brigatinib, and Lorlatinib?